Readers of IsraelNewsletter.com know that one of the Israeli firms we follow is Gilat Satellite (NASDAQ: GILT). In fact, my colleague Aaron Katzman and I have featured Gilat here on BloggingStocks and gave a synopsis of what we felt was the long case for Gilat.
We've speculated for months that Gilat was about to be acquired for a premium over its current stock price. The Israeli communications provider has been very active from a sales point of view, landing deals with the U.S. Postal Service, building a network for Verizon (NYSE: VZ) and expanding its global distribution. It had turned down offers earlier last year. Prominent hedge fund, York Capital, owned a big chunk of Gilat's debt, which it converted into stock last year, making it a 30% holder. Pretty bullish signal for Gilat.
Well, the firm announced that it is to be acquired by a group of investors for $11.40/share recently. I'm blogging this less as giving us a pat on the back (though, it does feel good to get one right) but to point out an interesting part of the deal.
The deal isn't supposed to close for another six months or so. Interestingly, in a squirmy market, this stock is trading almost 7% down from its acquisition price. A 6% return for six months, or an annualized 12%, isn't a bad return if you think the deal is going to go through. I won't handicap this deal, but the consortium appears serious about its offer and its ability to get the deal done. In a bad market, it's very possible that a deal like this falls through. We saw a similar thing occur with ECI Telecom, an Israeli buyout last year, that traded almost 10% below its purchase price leading right up to the deal.
Worth taking a look and doing the research.
Zack Miller is the managing editor of IsraelNewsletter.com and a former equity analyst for a leading multinational hedge fund.
Last updated: February 10, 2012: 07:44 AM
Hot Stocks
DailyFinance Headlines
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
- Why Used Car Bargains Are Getting Harder to Find
- 5 Reasons Facebook Stock May Be a Better Buy Than You Think
Benzinga Headlines
- How to Profit off Addicts
- The Pepsi Challenge for 8,700 People is to Find a New Job
- How to Profit From Surging Chinese Prices
- Credit Suisse is the Latest Swiss Bank to Disappoint
- Vodafone Misses Quarterly Revenue
TheFlyOnTheWall.com Headlines
- Greek workers launch general strike, NY Times says
- Realty Income downgraded to Sector Perform from Outperform at RBC Capital
- ValueVision renews three TV distribution agreements
- O'Charley's downgraded to Market Perform from Outperform at Morgan Keegan
- Alibaba Group to take private Hong Kong listed unit, Reuters reports
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
- Why Used Car Bargains Are Getting Harder to Find
- 5 Reasons Facebook Stock May Be a Better Buy Than You Think
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
The Money Man Behind Rick Santorum: Who Is Foster S. Friess?
Savings Experiment: Snow Removal

